United States · FDA National Drug Code directory
AMELUZ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70621-101_dc51c9c8-b764-4b34-802f-3f6814059dde
- Product NDC
- 70621-101
- Form
- GEL
- Composition / generic term
- aminolevulinic acid hydrochloride
- Labeler
- Biofrontera Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160826
- Source listing expiry
- 20271231
Source-listed ingredients
- AMINOLEVULINIC ACID HYDROCHLORIDE — 100 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 PACKAGE (70621-101-10) / 2 g in 1 TUBE (70621-101-01) · 70621-101-10
- 10 TUBE in 1 PACKAGE (70621-101-20) / 2 g in 1 TUBE (70621-101-01) · 70621-101-20
- 1 TUBE in 1 PACKAGE (70621-101-30) / 2 g in 1 TUBE (70621-101-03) · 70621-101-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →